omeprazole has been researched along with dactinomycin in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Daujat, M; Domergue, J; Fourtanier, G; Lesca, P; Maurel, P; Peryt, B | 1 |
| Okabe, S; Takahashi, S | 1 |
| Okabe, S; Takahashi, S; Yamazaki, T | 1 |
| Chen, D; Dornonville de la Cour, C; Håkanson, R; Lindström, E; Persson, L; Yamada, H; Zhao, CM | 1 |
| He, BS; Mi, QY; Pan, YQ; Tai, T; Xie, HG; Zhao, SL | 1 |
1 review(s) available for omeprazole and dactinomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for omeprazole and dactinomycin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Omeprazole, an inducer of human CYP1A1 and 1A2, is not a ligand for the Ah receptor.
Topics: Adult; Benzoflavones; beta-Naphthoflavone; Binding, Competitive; Blotting, Northern; Cell Fractionation; Cells, Cultured; Cycloheximide; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Dactinomycin; Enzyme Induction; Humans; Liver; Male; Omeprazole; Oxidoreductases; Poly A; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Receptors, Drug; RNA; RNA, Messenger | 1992 |
The cytoprotective effect of leminoprazole on indomethacin-induced damage to rabbit gastric mucosal cells.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Cells, Cultured; Cycloheximide; Dactinomycin; Dinoprostone; Gastric Mucosa; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Omeprazole; Rabbits | 1996 |
Leminoprazole protects cultured gastric mucosal cells against damage caused by ethanol, indometacin and taurocholate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cholagogues and Choleretics; Cycloheximide; Dactinomycin; Dinoprostone; Ethanol; Gastric Mucosa; Indomethacin; Male; Omeprazole; Oxytocics; Protein Synthesis Inhibitors; Rabbits; Solvents; Taurocholic Acid | 1997 |
Rat stomach ECL cells: mode of activation of histidine decarboxylase.
Topics: Animals; Cycloheximide; Dactinomycin; Enterochromaffin-like Cells; Enzyme Activation; Fasting; Food; Gastric Mucosa; Gastrins; Histidine Decarboxylase; Male; Omeprazole; Postprandial Period; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; Reserpine; RNA, Messenger | 2003 |
The molecular mechanism underlying the induction of hepatic MRP3 expression and function by omeprazole.
Topics: Biological Transport; Dactinomycin; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Indomethacin; Liver; Multidrug Resistance-Associated Proteins; Omeprazole; RNA, Small Interfering; Up-Regulation | 2015 |